Identification of the Scopularide Biosynthetic Gene Cluster in Scopulariopsis brevicaulis

Mie Bech Lukassen,Wagma Saei,Teis Esben Sondergaard,Anu Tamminen,Abhishek Kumar,Frank Kempken,Marilyn G. Wiebe,Jens Laurids Sørensen,Mie Lukassen,Teis Sondergaard,Marilyn Wiebe,Jens Sørensen
DOI: https://doi.org/10.3390/md13074331
2015-07-14
Marine Drugs
Abstract:Scopularide A is a promising potent anticancer lipopeptide isolated from a marine derived Scopulariopsis brevicaulis strain. The compound consists of a reduced carbon chain (3-hydroxy-methyldecanoyl) attached to five amino acids (glycine, l-valine, d-leucine, l-alanine, and l-phenylalanine). Using the newly sequenced S. brevicaulis genome we were able to identify the putative biosynthetic gene cluster using genetic information from the structurally related emericellamide A from Aspergillus nidulans and W493-B from Fusarium pseudograminearum. The scopularide A gene cluster includes a nonribosomal peptide synthetase (NRPS1), a polyketide synthase (PKS2), a CoA ligase, an acyltransferase, and a transcription factor. Homologous recombination was low in S. brevicaulis so the local transcription factor was integrated randomly under a constitutive promoter, which led to a three to four-fold increase in scopularide A production. This indirectly verifies the identity of the proposed biosynthetic gene cluster.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?